![](/img/cover-not-exists.png)
Response across multiple outcome measures in a randomized trial of extended-release memantine (28 mg, once daily) in patients with moderate-to-severe Alzheimer's disease
Graham, Stephen, Hendrix, Suzanne, Miller, Michael, Pejovic, Vojislav, Tocco, MichaelVolume:
8
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2012.05.1611
Date:
July, 2012
File:
PDF, 55 KB
english, 2012